Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lucica Glycated Albumin-L

K-Number: K170147 · 2017-10-12

Decision Date2017-10-12
Product CodeLCP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

Lucica Glycated Albumin-L is the device name listed in this FDA 510(k) record. The listed applicant is Asahi Kasei Pharma Corporation. It received FDA 510(k) clearance on 2017-10-12 under 510(k) number K170147. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lucica Glycated Albumin-L?

Lucica Glycated Albumin-L is a medical device that received FDA 510(k) clearance on 2017-10-12. The listed applicant is Asahi Kasei Pharma Corporation. The 510(k) number is K170147.

When did Lucica Glycated Albumin-L receive FDA 510(k) clearance?

Lucica Glycated Albumin-L received FDA 510(k) clearance on 2017-10-12, under 510(k) number K170147.

Who is the listed applicant for Lucica Glycated Albumin-L?

The FDA 510(k) record lists Asahi Kasei Pharma Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lucica Glycated Albumin-L?

The FDA product code for Lucica Glycated Albumin-L is LCP.

Related Devices (Code: LCP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.